Medicine guide

GLAVRINXA

As listed in the register: GLAVRINXA 1,5 MG/DOSIS SOLUCIÓN ORAL

1,5 mg/dosis · solución oral

  • Prescription only
  • Pain, sleep, mood, epilepsy and the brain
Active substance
Citisiniclina
Made by
Newline Pharma S.L.U.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupPain, sleep, mood, epilepsy and the brainN07BA04

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byNewline Pharma S.L.U.
Active substanceCitisiniclina
Used inPain, sleep, mood, epilepsy and the brain
Strength1,5 mg/dosis
Formsolución oral
ClassificationN07BA04 · Pain, sleep, mood, epilepsy and the brain
Routevía oral
MarketedNo — authorised but not currently marketed, according to the register
Name in the registerGLAVRINXA 1,5 MG/DOSIS SOLUCIÓN ORAL
Nº Registro91561

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician

Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.